Hematological malignancies are the types of cancer that are most intensively studied from cellular origin, genetic abnormality to drug resistance. Both scientific advances and clinical developments successfully benefit patients with blood cancer by improving our understanding of cancer biology and providing therapeutic avenues. Discoveries of molecular and cellular mechanisms governing hematopoietic homeostasis, lineage differentiation and function execution largely promote biological interpretation and therapeutic innovation for blood cancer.
Cellular therapy has seen great clinical promises over the past decade against some hematological malignancies, illustrated by 8 approved therapeutic products worldwide. In parallel with the rapidly-evolving clinical practice, scientific research has been focused on rigorous elucidation of how immune cells mediate certain biological processes to exert antitumor function. These findings have enabled further advancement to ameliorate the therapeutic potency of immune cells targeting blood cancer, as well as to extend cellular therapy towards solid tumor, autoimmune disease and aging.
This meeting co-hosted by Cell Research and Zhejiang University will bring together the most updated breakthroughs in the field of hematology and cellular therapy. From the perspectives of understanding malignant progression and enhancing therapeutic efficacy, we envision this symposium bridging basic research and clinical practice of malignant hematological diseases and cellular therapy through insights sharing, cross-disciplinary discussion and collaboration fostering.
Professor
University of Cambridge
Strategy Advisory Committee Member, Wellcome-MRC Cambridge Stem Cell Institute
Fellow, the Academy of Medical Sciences
Professor
Yale University
Arthur H. and Isabel Bunker Professor of Medicine (Hematology)
Director, Center of Molecular and Cellular Oncology
Chief, Cellular and Molecular Oncology
HHMI Faculty Scholar
Professor
Peking Union Medical College
President, the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Director, State Key Laboratory of Experimental Hematology
Professor
Zhejiang University
Qiushi Distinguished Professor, Zhejiang University
President, the First Affiliated Hospital, Zhejiang University School of Medicine
Director, Zhejiang University Institute of Hematology
Professor
City of Hope
Deputy Director, T Cell Therapeutics Research Laboratory (TCTRL)
Heritage Provider, Network in Immunotherapy
Professor
City of Hope
Chair, Simms/Mann Family Foundation in Systems Biology
Chair, Department of Systems Biology
Professor
City of Hope
Distinguished Chair, Francis & Kathleen McNamara in Hematology and Hematopoietic Cell Transplantation
Director, Hematologic Malignancies and Stem Cell Transplantation Institute
Professor
University of Colorado
Chief, Division of Hematology, Anachutz Medical Campus
Professor
The University of Hong Kong
Chief, the Division of Haematology, Oncology and Bone Marrow Transplantation at the Department of Medicine, School of Clinical Medicine
Professor
Tel Aviv University
Head, Haemato-oncology and Cord Blood Bank, Chaim Sheba, Israel
Professor
Soochow University
Chief Physician, the First Affiliated Hospital of Soochow University
Deputy Director, Jiangsu Institute of Hematology
Professor
Wuhan University
Professor
Zhejiang University
Professor
ShanghaiTech University
Principal Investigator
Blood Oncology Research Group, Key Laboratory of Cancer and microenvironment, Shanghai Institute of Nutrition and Health, CAS
Co-founder and Chief Scientific Officer
Hangzhou Qihan Biotechnology Co., Ltd
Professor
Wuhan University
Professor
Zhejiang University
Professor
Peking Union Medical College
Vice President, the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Deputy Director, State Key Laboratory of Experimental Hematology
Professor
Army Medical University
Director and Chief Physician, the Medical Center of Hematology, Xinqiao Hospital
Professor
Sun Yat-sen University
Professor
Shanghai Jiaotong University
Vice President, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Deputy Director, Shanghai Institute of Hematology
Professor
Shanghai Jiao Tong University
Assoiate Dean, Shanghai Jiao Tong University School of Medicine
Deputy Director, the Department of Pathology and Physiology, School of Basic Medicine, Shanghai Jiao Tong University School of Medicine
Professor
Capital Medical University
Chief Physician, Hematology Department, Beijing Chao-Yang Hospital
Cell Research
The First Affiliated Hospital, Zhejiang University School of Medicine
Zhejiang Society for Immunology
Liangzhu Laboratory
? Copyright 2023 Cell Research Symposium - All rights reserved.
